DTIL PRECISION BIOSCIENCES INC
Healthcare · Biological Products, (No Diagnostic Substances) · Market cap: $211.3M
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $51.4K | $0 |
| 2022-Q2 | $50.7K | $75.4K |
| 2022-Q3 | $59.7K | $0 |
| 2022-Q4 | $0 | $14.5K |
| 2023-Q1 | $17.2K | $61.7K |
| 2023-Q2 | $0 | $16.2K |
| 2023-Q3 | $43.2K | $0 |
| 2023-Q4 | $0 | $56.4K |
| 2024-Q1 | $0 | $75.2K |
| 2024-Q2 | $0 | $27.2K |
| 2024-Q3 | $0 | $0 |
| 2024-Q4 | $81.3K | $29.5K |
| 2025-Q1 | $47.1K | $271.5K |
| 2025-Q2 | $28.1K | $0 |
| 2025-Q3 | $20.3K | $63.2K |
| 2025-Q4 | $33.7K | $34.9K |
| 2026-Q1 | $0 | $431.3K |
| 2026-Q2 | $0 | $0 |
| 2026-Q3 | $29.5K | $0 |
| 2026-Q4 | $0 | $27.5K |
Bought$462.1K24 buy days
Sold$1.2M43 sell days
Net insider flow-$722.4Knet selling · 5 years
Latest trade2026-11-10Scimeca Dario
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-11-10 | Sell | Scimeca Dario | Other C-suite | 2,821 | $9.75 | $27.5K | 1 |
| 2026-09-28 | Buy | Frankel Stanley | Director | 1,000 | $6.00 | $6.0K | 1 |
| 2026-09-25 | Buy | Germano Geno J | Director | 2,609 | $6.28 | $16.4K | 1 |
| 2026-09-25 | Buy | Brown Melinda | Director | 1,135 | $6.27 | $7.1K | 1 |
| 2026-02-18 | Sell | Amoroso Michael | CEO | 20,559 | $3.84 | $78.9K | 1 |
| 2026-02-18 | Sell | Kelly John Alexander | CFO | 8,149 | $3.84 | $31.3K | 1 |
| 2026-02-18 | Sell | Scimeca Dario | General counsel | 4,925 | $3.84 | $18.9K | 1 |
| 2026-02-18 | Sell | SMITH J. JEFFERSON | Other C-suite | 4,925 | $3.84 | $18.9K | 1 |
| 2026-01-22 | Sell | Amoroso Michael | CEO | 34,799 | $4.17 | $145.1K | 1 |
| 2026-01-21 | Sell | Kelly John Alexander | CFO | 15,213 | $4.03 | $61.3K | 1 |
| 2026-01-21 | Sell | SMITH J. JEFFERSON | Other C-suite | 10,200 | $4.03 | $41.1K | 1 |
| 2026-01-21 | Sell | Scimeca Dario | General counsel | 8,854 | $4.03 | $35.7K | 1 |
| 2025-12-16 | Buy | Germano Geno J | Director | 3,000 | $4.72 | $14.2K | 1 |
| 2025-12-16 | Buy | Frankel Stanley | Director | 2,700 | $4.70 | $12.7K | 1 |
| 2025-12-15 | Buy | Brown Melinda | Director | 1,381 | $4.97 | $6.9K | 1 |
| 2025-11-03 | Sell | Amoroso Michael | CEO | 3,409 | $6.49 | $22.1K | 1 |
| 2025-11-03 | Sell | Kelly John Alexander | CFO | 1,303 | $6.49 | $8.5K | 1 |
| 2025-11-03 | Sell | Scimeca Dario | General counsel | 665 | $6.49 | $4.3K | 1 |
| 2025-09-26 | Buy | Frankel Stanley | Director | 2,700 | $4.97 | $13.4K | 1 |
| 2025-09-22 | Buy | Brown Melinda | Director | 1,400 | $4.89 | $6.8K | 1 |
| 2025-07-03 | Sell | Kelly John Alexander | CFO | 14,827 | $4.26 | $63.2K | 1 |
| 2025-06-25 | Buy | Buehler Kevin | Director | 5,076 | $4.16 | $21.1K | 1 |
| 2025-06-25 | Buy | Brown Melinda | Director | 1,682 | $4.14 | $7.0K | 1 |
| 2025-03-26 | Buy | Buehler Kevin | Director | 4,523 | $4.67 | $21.1K | 1 |
| 2025-03-26 | Buy | Brown Melinda | Director | 1,839 | $4.75 | $8.7K | 1 |
| 2025-03-25 | Buy | Germano Geno J | Director | 3,250 | $5.30 | $17.2K | 1 |
| 2025-03-24 | Sell | Amoroso Michael | CEO | 964 | $5.56 | $5.4K | 1 |
| 2025-03-04 | Sell | Scimeca Dario | General counsel | 272 | $4.91 | $1.3K | 1 |
| 2025-03-04 | Sell | SMITH J. JEFFERSON | Other C-suite | 154 | $4.91 | $756 | 1 |
| 2025-01-22 | Sell | SMITH J. JEFFERSON | Other C-suite | 10,287 | $4.79 | $49.3K | 1 |
| 2025-01-22 | Sell | Scimeca Dario | General counsel | 8,928 | $4.79 | $42.8K | 1 |
| 2025-01-21 | Sell | Amoroso Michael | CEO | 36,838 | $4.67 | $172.0K | 1 |
| 2024-12-30 | Buy | Germano Geno J | Director | 3,605 | $4.49 | $16.2K | 1 |
| 2024-12-27 | Buy | Buehler Kevin | Director | 4,320 | $4.88 | $21.1K | 1 |
| 2024-12-27 | Buy | Kelly John Alexander | CFO | 2,113 | $4.75 | $10.0K | 1 |
| 2024-12-26 | Buy | Brown Melinda | Director | 3,016 | $4.55 | $13.7K | 1 |
| 2024-11-21 | Buy | Kelly John Alexander | CFO | 3,000 | $6.76 | $20.3K | 1 |
| 2024-11-04 | Sell | Amoroso Michael | CEO | 3,012 | $8.19 | $24.7K | 1 |
| 2024-11-04 | Sell | Scimeca Dario | General counsel | 588 | $8.19 | $4.8K | 1 |
| 2024-06-10 | Sell | Scimeca Dario | General counsel | 93 | $11.79 | $1.1K | 1 |
| 2024-06-10 | Sell | SMITH J. JEFFERSON | Other C-suite | 50 | $11.79 | $590 | 1 |
| 2024-05-02 | Sell | Amoroso Michael | CEO | 1,526 | $10.32 | $15.7K | 1 |
| 2024-05-02 | Sell | List Alan | Other C-suite | 290 | $10.32 | $3.0K | 1 |
| 2024-05-02 | Sell | Scimeca Dario | General counsel | 272 | $10.32 | $2.8K | 1 |
| 2024-05-02 | Sell | SMITH J. JEFFERSON | Other C-suite | 154 | $10.32 | $1.6K | 1 |
| 2024-04-30 | Sell | List Alan | Other C-suite | 238 | $10.03 | $2.4K | 1 |
| 2024-01-23 | Sell | SMITH J. JEFFERSON | Other C-suite | 28,000 | $0.37 | $10.4K | 1 |
| 2024-01-22 | Sell | Amoroso Michael | CEO | 137,390 | $0.36 | $49.5K | 1 |
| 2024-01-22 | Sell | List Alan | Other C-suite | 21,526 | $0.36 | $7.7K | 1 |
| 2024-01-22 | Sell | Scimeca Dario | General counsel | 21,287 | $0.36 | $7.7K | 1 |
| 2023-11-03 | Sell | Amoroso Michael | CEO | 125,025 | $0.40 | $50.0K | 1 |
| 2023-11-03 | Sell | Scimeca Dario | General counsel | 16,023 | $0.40 | $6.4K | 1 |
| 2023-08-18 | Buy | Kelly John Alexander | CFO | 90,000 | $0.48 | $43.2K | 1 |
| 2023-06-08 | Sell | Scimeca Dario | General counsel | 13,361 | $0.75 | $10.0K | 1 |
| 2023-04-27 | Sell | List Alan | Other C-suite | 7,771 | $0.79 | $6.1K | 1 |
| 2023-03-22 | Sell | Amoroso Michael | CEO | 46,999 | $0.82 | $38.5K | 1 |
| 2023-03-17 | Buy | Kelly John Alexander | CFO | 20,000 | $0.86 | $17.2K | 1 |
| 2023-03-06 | Sell | Scimeca Dario | General counsel | 12,172 | $1.07 | $13.0K | 1 |
| 2023-03-06 | Sell | List Alan | Other C-suite | 9,473 | $1.07 | $10.1K | 1 |
| 2022-10-17 | Sell | Amoroso Michael | CEO | 11,006 | $1.32 | $14.5K | 1 |
| 2022-09-23 | Buy | Kelly John Alexander | CFO | 8,200 | $1.23 | $10.1K | 1 |
| 2022-09-22 | Buy | Kelly John Alexander | CFO | 37,037 | $1.34 | $49.6K | 1 |
| 2022-06-22 | Buy | Kelly John Alexander | CFO | 33,784 | $1.50 | $50.7K | 1 |
| 2022-06-08 | Sell | JANTZ DEREK | Other C-suite | 18,849 | $2.06 | $38.8K | 1 |
| 2022-06-08 | Sell | Scimeca Dario | General counsel | 9,833 | $2.06 | $20.3K | 1 |
| 2022-04-27 | Sell | List Alan | Other C-suite | 7,775 | $2.10 | $16.3K | 1 |
| 2022-03-17 | Buy | Kelly John Alexander | CFO | 16,677 | $3.08 | $51.4K | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Amoroso Michael | CEO | $0 | $616.5K | 2026-02-18 |
| Kelly John Alexander | CFO | $252.5K | $164.2K | 2026-02-18 |
| Scimeca Dario | Other C-suite | $0 | $196.6K | 2026-11-10 |
| SMITH J. JEFFERSON | Other C-suite | $0 | $122.6K | 2026-02-18 |
| Germano Geno J | Director | $64.0K | $0 | 2026-09-25 |
| Buehler Kevin | Director | $63.3K | $0 | 2025-06-25 |
| Brown Melinda | Director | $50.2K | $0 | 2026-09-25 |
| List Alan | Other C-suite | $0 | $45.7K | 2024-05-02 |
| JANTZ DEREK | Other C-suite | $0 | $38.8K | 2022-06-08 |
| Frankel Stanley | Director | $32.1K | $0 | 2026-09-28 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
| Window | Insiders | Total | Score | 21 days vs benchmark | 63 days vs benchmark | 126 days vs benchmark | Status |
|---|---|---|---|---|---|---|---|
| 2026-09-25 → 2026-09-28 | 3 | $29.5K | 39 | +10.8% (+11.5% raw) | – | – | active |
| 2025-12-15 → 2025-12-16 | 3 | $33.7K | 36 | -19.6% (-14.7% raw) | +36.4% (+33.3% raw) | +25.2% (+44.8% raw) | closed |
| 2025-03-25 → 2025-03-26 | 3 | $47.1K | 38 | +14.2% (+10.1% raw) | -17.4% (-11.6% raw) | -11.6% (+7.2% raw) | closed |
| 2024-12-26 → 2024-12-30 | 4 | $61.0K | 42 | +6.6% (+7.4% raw) | +22.7% (+8.3% raw) | -0.3% (-0.9% raw) | closed |
| 2019-04-01 → 2019-04-03 | 3 | $1.7M | 34 | -14.3% (-14.3% raw) | -13.2% (-9.6% raw) | -52.9% (-50.8% raw) | closed |
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.